Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roadzen (RDZN) Cash from Financing Activities (2022 - 2025)

Historic Cash from Financing Activities for Roadzen (RDZN) over the last 4 years, with Q4 2025 value amounting to $7.4 million.

  • Roadzen's Cash from Financing Activities rose 16824.22% to $7.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $20.5 million, marking a year-over-year increase of 4628.29%. This contributed to the annual value of $11.7 million for FY2025, which is 5369.83% down from last year.
  • Per Roadzen's latest filing, its Cash from Financing Activities stood at $7.4 million for Q4 2025, which was up 16824.22% from $7.1 million recorded in Q3 2025.
  • In the past 5 years, Roadzen's Cash from Financing Activities registered a high of $12.4 million during Q2 2023, and its lowest value of $300000.0 during Q2 2022.
  • Over the past 4 years, Roadzen's median Cash from Financing Activities value was $2.8 million (recorded in 2024), while the average stood at $3.8 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first surged by 402559.23% in 2023, then crashed by 9165.25% in 2024.
  • Over the past 4 years, Roadzen's Cash from Financing Activities (Quarter) stood at $2.6 million in 2022, then tumbled by 60.8% to $1.0 million in 2023, then surged by 169.55% to $2.8 million in 2024, then surged by 168.24% to $7.4 million in 2025.
  • Its Cash from Financing Activities was $7.4 million in Q4 2025, compared to $7.1 million in Q3 2025 and $1.4 million in Q2 2025.